Chemical and Biological Profile of Dual Cdk1 and Cdk2 Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-5968|3|1|1-14

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.3, Iss.1, 2003-01, pp. : 1-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis and Biological Evaluation of Scutellaria Flavone Cyclaneaminol Mannich Base Derivatives as Novel CDK1 Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 7, 2016-05 ,pp. : 914-924

Bentham Science Publishers

Access to resources Recommend Favorite

δEF1 upregulates CDK4 transcription via the E2box element on the CDK4 promoter

By              

Experimental and Therapeutic Medicine, Vol. 7, Iss. 1, 2014-01 ,pp. : 161-164

Spandidos Publications

Access to resources Recommend Favorite

An Analysis of the Binding Modes of ATP-Competitive CDK2 Inhibitors as Revealed by X-Ray Structures of Protein-Inhibitor Complexes

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 5, 2005-09 ,pp. : 561-573

Bentham Science Publishers

Access to resources Recommend Favorite

Implication of Malignancy and Prognosis of p27 kip1 , Cyclin E, and Cdk2 Expression in Epithelial Ovarian Tumors

By Sui L.   Dong Y.   Ohno M.   Sugimoto K.   Tai Y.   Hando T.   Tokuda M.  

Gynecologic Oncology, Vol. 83, Iss. 1, 2001-10 ,pp. : 56-63

Elsevier

Access to resources Recommend Favorite

HOXA7 stimulates human hepatocellular carcinoma proliferation through cyclin E1/CDK2

By  

Oncology Reports, Vol. 33, Iss. 2, 2015-01 ,pp. : 990-996

Spandidos Publications

Access to resources Recommend Favorite